MasterControl Launches AI to Overhaul Life Sciences Compliance

SALT LAKE CITY, UT – January 27, 2026 – MasterControl, a major provider of software for regulated industries, today launched its AI-powered SOP Analyzer, a tool designed to radically shorten the time life sciences companies spend ensuring their procedural documents meet stringent regulatory standards.

The new solution promises to reduce the update cycle for Standard Operating Procedures (SOPs) from days to mere hours, tackling one of the most persistent and labor-intensive challenges in the pharmaceutical and medical device sectors. By leveraging artificial intelligence, the company aims to shift the paradigm from reactive, manual compliance checks to proactive, automated analysis, potentially transforming the landscape of quality management.

The Crushing Weight of Compliance Paperwork

For life sciences manufacturers, maintaining an accurate and compliant library of SOPs is a monumental task. These documents form the backbone of quality control, dictating every step of the manufacturing process to ensure product safety and efficacy. However, the process of managing them is fraught with challenges. Quality teams spend hundreds of hours each quarter monitoring evolving global regulations, reviewing dense procedural documents, and managing updates, approvals, and retraining.

This administrative burden creates significant risk. According to data from MasterControl's beta program for the new tool, nearly half of the participants reported a lack of confidence that their SOPs were consistently audit-ready. This often leaves companies exposed, forcing them into reactive fixes only after a regulatory inspection uncovers compliance gaps. The market for solutions is booming, with the life sciences quality management software sector, valued at over $3 billion in 2024, projected to nearly triple by 2033 as companies flee paper-based systems for digital platforms.

One beta participant highlighted a common industry pain point: "Our biggest challenge is keeping track of the regulatory requirements in different countries and regions and staying in compliance with the regulation changes."

AI as the New Compliance Officer

MasterControl's SOP Analyzer enters this high-stakes environment by using advanced AI to automate the review process. The system employs Retrieval-Augmented Generation (RAG) technology, which combines the text-generation capabilities of large language models with a secure, external knowledge base of regulatory requirements. This allows the tool to check an SOP against specific regulations, identify potential gaps, and provide actionable suggestions for improvement, all while minimizing the risk of AI “hallucinations” or fabricated information.

"SOP Analyzer marks a fundamental shift in how organizations manage SOP compliance," said Sue Marchant, Chief Product Officer at MasterControl. "By automating document reviews and embedding regulatory intelligence, it reduces SOP update cycles from days to hours... This allows quality professionals to move beyond manual review and focus on higher-value work that drives continuous improvement, operational excellence, and innovation."

The technology is built on the company's ADAPT Platform, which was developed in alignment with ISO 42001, an international standard for responsible AI management. Alex Kaplunov, Chief Technology Officer at MasterControl, noted that this foundation “enables the development of specialized AI services that understand the regulatory, manufacturing, and quality context unique to life sciences.”

A Competitive Race to Automate Quality

The launch places MasterControl in a heated race among technology providers vying to integrate AI into the lucrative life sciences quality management space. The company is not alone in its vision. Competitors are also aggressively deploying AI to streamline quality workflows.

Veeva Systems, a dominant force in life sciences cloud software, recently announced its own strategic initiative to embed agentic AI across its platform, promising review cycle reductions of up to 75%. Similarly, Sparta Systems, a Honeywell company, has been enhancing its TrackWise QMS with AI capabilities since 2019, using machine learning to detect high-risk events and generate summaries from quality data. Other players, from Dassault Systèmes to smaller specialized providers, are all integrating AI to tackle the industry's complex data and documentation challenges.

What may set different solutions apart is the depth of their regulatory understanding and the seamlessness of their integration into existing workflows. As MasterControl plans to continually expand the scope of its analyzer's regulatory knowledge, its value will be measured by its ability to help clients navigate a complex web of international rules more effectively than its rivals.

Redefining Roles in a Regulated World

The introduction of powerful AI tools like the SOP Analyzer is poised to reshape the roles of quality and regulatory professionals. The goal is not to replace human experts but to augment their capabilities, freeing them from the tedium of manual document comparison and allowing them to apply their expertise to more strategic challenges. This shift requires a new focus on what is often termed the "human-in-the-loop" model, where AI provides the analysis and humans provide the final judgment and contextual understanding.

Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are watching this technological evolution closely. While they encourage innovations that can improve efficiency and safety, they also demand stringent validation, transparency, and human oversight. The use of AI in GxP-regulated environments (good practice guidelines) comes with a high bar for proving that the technology is reliable and that accountability for compliance remains firmly in human hands.

Companies adopting these tools must therefore navigate not only the technological implementation but also the associated risks of algorithmic bias, data security, and IP protection. The ultimate responsibility for an error suggested by an AI will still fall on the manufacturer. This underscores the importance of robust internal processes that treat AI-generated suggestions as just that—suggestions that require expert human review before being implemented. As automation handles more routine tasks, the premium on human critical thinking, strategic oversight, and ethical judgment in the life sciences industry will only continue to grow.